We only have this paper's title and publication details.
Read it at the sourceObservational analysis evaluates efficacy of durvalumab and bevacizumab with transarterial chemoembolization in unresectable hepatocellular carcinoma, suggesting a new treatment approach.
No takes yet. Share an insight, caveat, or question.
Abdelrahim et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: